Cigna Group stock: UBS keeps buy rating for Cigna Group stock
Published on 10/21/2026 at 17:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst rating and price
- UBS Group restated its buy rating on October 1, 2026.
- Second-quarter revenue reached USD 71.67 billion for the period ended June 30, 2026.
- Cigna Group stock costs EUR 272.15 at Lang & Schwarz on October 21, 2026 at 5:33 p.m. CEST, plus 0.13 percent versus the Xetra close of EUR 271.80 and 1.88 percent below its 52-week high.
- The next earnings report is scheduled for November 5, 2026, before the market opens.
According to MarketBeat on October 1, 2026, UBS Group restated a buy rating on Cigna Group. Cigna Group stock was trading at EUR 272.15 at Lang & Schwarz on October 21, 2026 at 5:33 p.m. CEST, plus 0.13 percent versus the Xetra close of October 21, 2026 at EUR 271.80.
Revenue reached USD 71.67 billion
The Cigna Group reported total revenue of USD 71.67 billion in the second quarter ended June 30, 2026, according to the Yahoo Finance earnings transcript dated July 30, 2026. Adjusted earnings per share reached USD 7.78, while full-year 2026 adjusted earnings per share guidance rose to at least USD 30.45. Evernorth revenue increased 6.00 percent year over year to USD 61.50 billion.
Stock sits 1.88 percent below high
The primary-market quote was USD 305.48 on the NYSE at 11:34 a.m. ET on October 21, 2026. The 52-week range was USD 239.51 to USD 311.34, placing the stock 1.88 percent below the high and 27.54 percent above the low. Market capitalization stood at USD 80.7 billion, and the price-to-earnings ratio was 12.66.
November 5 brings the next report
The next earnings report is scheduled for November 5, 2026, before the market opens, according to MindTrajour. The prior report was released before the market opened on July 30, 2026, giving investors a clear date for the next quarterly update.
Comparison with peers
Cigna Group: plus 0.13 percent versus the Xetra close, price-to-earnings ratio 12.66, market capitalization USD 80.7 billion.
UnitedHealth Group Incorporated (NYSE, USD): minus 0.75 percent, price-to-earnings ratio 23.76, market capitalization USD 373.5 billion.
Humana Inc. (NYSE, USD): plus 0.04 percent, price-to-earnings ratio 40.52, market capitalization USD 51.3 billion.
Cigna Group stock after the Xetra close
The euro quote was EUR 272.15 at Lang & Schwarz on October 21, 2026 at 5:33 p.m. CEST, or plus 0.13 percent against the Xetra close of EUR 271.80 dated October 21, 2026. The modest spread leaves the stock 1.88 percent below its USD 311.34 52-week high on the NYSE.
The further course of trading is shown by the continuously updated real-time quote of Cigna Group stock.
Cigna Group stock facts
- Company: The Cigna Group
- ISIN: US1255231003
- Ticker: CI
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 21, 2026, 5:33 p.m. CEST): EUR 272.15
- Change versus Xetra close: plus 0.13 percent
- Xetra close (October 21, 2026): EUR 271.80
- Market capitalization: USD 80.7 billion (as of October 21, 2026)
- 52-week range: USD 239.51-311.34 (as of October 21, 2026)
- Sector / Industry: Healthcare / Medical - Healthcare Plans
- Index membership: S&P 500
- Next earnings date: November 5, 2026
Market context: Market report S&P 500.
